28 (Bloomberg) -- GlaxoSmithKline Plc's Advair Diskus inhaler cut the risk of death in people with a lung condition caused by smoking more than Boehringer ...
all 60 news articles
Dr. Reisner played a diverse and integral role in the development of several key products including Advair(R) Diskus(R) and Serevent(R) Diskus(R) for COPD, ...
Moreover, the higher-strength version of Glaxo's inhaled Advair Diskus for chronic obstructive pulmonary disease has not been given final approval. ...
Advair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. ...
... Sanofi-Aventis' weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline's Advair Diskus for bronchitis and emphysema symptoms. ...
... Sanofi-Aventis’ weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline’s Advair Diskus for bronchitis and emphysema symptoms. ...
Advair Diskus may increase this risk, therefore, bone mineral density assessment is recommended prior to starting Advair Diskus and periodically thereafter. ...
FDA has issued a not approvable letter for GlaxoSmithKline's supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate ...
all 7 news articles